Shopping Cart 0
Cart Subtotal
USD 0

Eli Lilly and Co (LLY) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It also provides pet medicine, food-safety products and companion animal health products, besides services to the food animal industry. Lilly also has mid-to-late stage pipeline products. The company distributes human pharmaceutical and animal health products through independent wholesale distributors. It also promotes its products through sales representatives and marketing agreements with other pharmaceutical companies. The company offers its products in North America, South America, Europe, South Asia, the Middle East, Africa and North Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.

Eli Lilly and Co (LLY)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Eli Lilly and Co, Medical Equipment, Deal Details 12

Asset Purchase 12

Eli Lilly Acquires Rights to Intranasal Glucagon from Locemia Solutions 12

Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 13

Venture Financing 14

EdiGene Raises USD15 Million in Pre-Series B Venture Financing 14

Rimidi Raises USD6.6 Million in Series A-1 Financing 15

Avedro Raises USD25 Million in Venture Financing 16

Veritas Genetics Raises USD30 Million in Series B Financing 18

Millin Enterprises Raises Funds through Series A financing 19

ACEA Biosciences Raises USD30 Million in Venture Financing 20

Microtech Medical Raises Funds through Series A Financing 21

Veritas Genetics Raises USD10 Million in Series A Financing Round 22

Companion Medical Raises USD3.15 Million in Series B Financing 23

Private Equity 24

Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 24

Partnerships 25

Eli Lilly and Livongo Health Enter into Partnership 25

Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 26

DexCom Enters into Agreement with Eli Lilly 27

Insulet Enters into Co-Development Agreement with Eli Lilly 28

Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 29

Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 30

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 31

Corgenix Enters Into Co-Development Agreement With Eli Lilly 32

Insulet Enters Into Co-Development Agreement With Eli Lilly 33

Qiagen Enters Into Co-Development Agreement With Eli Lilly 34

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 35

PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 36

Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 37

Eli Lilly Enters into Licensing Agreement with Transcriptic 38

Equity Offering 39

Leap Therapeutics to Raise USD18 Million in Private Placement of Units 39

Eli Lilly and Co-Key Competitors 41

Eli Lilly and Co-Key Employees 42

Eli Lilly and Co-Locations And Subsidiaries 44

Head Office 44

Other Locations & Subsidiaries 44

Joint Venture 52

Recent Developments 53

Strategy And Business Planning 53

Sep 07, 2017: Lilly Takes Steps To Streamline Business, Invest In New Medicines And Drive Growth 53

Financial Announcements 54

Jul 24, 2018: Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance 54

Apr 24, 2018: Lilly Reports First-Quarter 2018 Financial Results 57

Jan 31, 2018: Lilly Reports Strong Fourth-Quarter and Full-Year 2017 Revenue Growth, Increases 2018 EPS Guidance 62

Dec 13, 2017: Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020 68

Oct 24, 2017: Lilly Reports Third-Quarter Results 2017 69

Jul 25, 2017: Lilly Reports Second-Quarter Results 74

Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 78

Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 82

Corporate Communications 88

May 23, 2018: Eli Lilly and Company Announces Retirement Of Sue Mahony As President Of Lilly Oncology 88

Mar 09, 2018: Maura Dickler, M.D. To Become Vice President Of Late Phase Development At Lilly Oncology 89

Dec 11, 2017: Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology 90

Nov 13, 2017: Lilly Appoints Philip Johnson to Senior Vice President and Treasurer 91

Sep 29, 2017: Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing 92

Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 93

May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 94

Mar 02, 2017: Lilly Announces Changes In Senior Management 95

Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 96

Legal and Regulatory 97

Aug 30, 2018: Adocia announces update to second arbitration against Eli Lilly & Company 97

Government and Public Interest 98

Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 98

Other Significant Developments 99

Sep 25, 2017: Geisinger And Boehringer Ingelheim Collaborate To Create A Predictive Model To Help Improve Health Outcomes For People With Type 2 Diabetes 99

Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 100

May 17, 2017: Cogstate Selected as Preferred Provider to Lilly's Alzheimer's Disease Platform 101

Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 102

Appendix 103

Methodology 103

About GlobalData 103

Contact Us 103

Disclaimer 103


List Of Figure

List of Figures

Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Eli Lilly and Co, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Eli Lilly and Co, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Eli Lilly and Co, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Eli Lilly and Co, Medical Equipment, Key Facts, 2017 2

Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Eli Lilly and Co, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Eli Lilly and Co, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Eli Lilly and Co, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Eli Lilly and Co, Deals By Market, 2012 to YTD 2018 9

Eli Lilly and Co, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Eli Lilly Acquires Rights to Intranasal Glucagon from Locemia Solutions 12

Eli Lilly Acquires Two Alzheimer's Disease Imaging Agents From Siemens Medical Solutions 13

EdiGene Raises USD15 Million in Pre-Series B Venture Financing 14

Rimidi Raises USD6.6 Million in Series A-1 Financing 15

Avedro Raises USD25 Million in Venture Financing 16

Veritas Genetics Raises USD30 Million in Series B Financing 18

Millin Enterprises Raises Funds through Series A financing 19

ACEA Biosciences Raises USD30 Million in Venture Financing 20

Microtech Medical Raises Funds through Series A Financing 21

Veritas Genetics Raises USD10 Million in Series A Financing Round 22

Companion Medical Raises USD3.15 Million in Series B Financing 23

Lilly Asia Ventures and HighLight Capital Invests USD77 Million in Sansure Biotech 24

Eli Lilly and Livongo Health Enter into Partnership 25

Eli Lilly and Co Enters into Co-Development Agreement with Rimidi Diabetes 26

DexCom Enters into Agreement with Eli Lilly 27

Insulet Enters into Co-Development Agreement with Eli Lilly 28

Qiagen Enters into Co-Development Agreement with Eli Lilly for Companion Diagnostic Test 29

Qiagen And Eli Lilly Enter Into Co-Development Agreement For Companion Diagnostic Test 30

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 31

Corgenix Enters Into Co-Development Agreement With Eli Lilly 32

Insulet Enters Into Co-Development Agreement With Eli Lilly 33

Qiagen Enters Into Co-Development Agreement With Eli Lilly 34

Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests 35

PrimeraDx Enters Into Co-Development Agreement With Eli Lilly 36

Cardinal Health Enters Into Co-Marketing Agreement With Eli Lilly For Amyvid 37

Eli Lilly Enters into Licensing Agreement with Transcriptic 38

Leap Therapeutics to Raise USD18 Million in Private Placement of Units 39

Eli Lilly and Co, Key Competitors 41

Eli Lilly and Co, Key Employees 42

Eli Lilly and Co, Subsidiaries 44

Eli Lilly and Co, Joint Venture 52

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Eli Lilly and Co, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.